187 related articles for article (PubMed ID: 23467544)
1. Suppression of endoplasmic reticulum stress-induced invasion and migration of breast cancer cells through the downregulation of heparanase.
Li Y; Liu H; Huang YY; Pu LJ; Zhang XD; Jiang CC; Jiang ZW
Int J Mol Med; 2013 May; 31(5):1234-42. PubMed ID: 23467544
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of extracellular superoxide dismutase attenuates heparanase expression and inhibits breast carcinoma cell growth and invasion.
Teoh ML; Fitzgerald MP; Oberley LW; Domann FE
Cancer Res; 2009 Aug; 69(15):6355-63. PubMed ID: 19602586
[TBL] [Abstract][Full Text] [Related]
3. Tunicamycin-induced endoplasmic reticulum stress reduces in vitro subpopulation and invasion of CD44+/CD24- phenotype breast cancer stem cells.
Nami B; Donmez H; Kocak N
Exp Toxicol Pathol; 2016 Aug; 68(7):419-26. PubMed ID: 27350212
[TBL] [Abstract][Full Text] [Related]
4. The heparanase inhibitor PG545 is a potent anti-lymphoma drug: Mode of action.
Weissmann M; Bhattacharya U; Feld S; Hammond E; Ilan N; Vlodavsky I
Matrix Biol; 2019 Apr; 77():58-72. PubMed ID: 30096360
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Heparanase Expression Results in Suppression of Invasion, Migration and Adhesion Abilities of Bladder Cancer Cells.
Tatsumi Y; Miyake M; Shimada K; Fujii T; Hori S; Morizawa Y; Nakai Y; Anai S; Tanaka N; Konishi N; Fujimoto K
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32471161
[TBL] [Abstract][Full Text] [Related]
6. [Effects of cisplatin combined with heparanase inhibitor on proliferation and invasion of human nasopharyngeal carcinoma cells].
Li Y; Liu H; Huang YY; Pu LJ; Zhang XD; Jiang ZW; Jiang CC
Yao Xue Xue Bao; 2013 Apr; 48(4):609-14. PubMed ID: 23833953
[TBL] [Abstract][Full Text] [Related]
7. Heparanase degrades syndecan-1 and perlecan heparan sulfate: functional implications for tumor cell invasion.
Reiland J; Sanderson RD; Waguespack M; Barker SA; Long R; Carson DD; Marchetti D
J Biol Chem; 2004 Feb; 279(9):8047-55. PubMed ID: 14630925
[TBL] [Abstract][Full Text] [Related]
8. Heparanase neutralizes the anticoagulation properties of heparin and low-molecular-weight heparin.
Nasser NJ; Sarig G; Brenner B; Nevo E; Goldshmidt O; Zcharia E; Li JP; Vlodavsky I
J Thromb Haemost; 2006 Mar; 4(3):560-5. PubMed ID: 16460439
[TBL] [Abstract][Full Text] [Related]
9. Structure-based design of a selective heparanase inhibitor as an antimetastatic agent.
Ishida K; Hirai G; Murakami K; Teruya T; Simizu S; Sodeoka M; Osada H
Mol Cancer Ther; 2004 Sep; 3(9):1069-77. PubMed ID: 15367701
[TBL] [Abstract][Full Text] [Related]
10. Regulation of heparanase gene expression by estrogen in breast cancer.
Elkin M; Cohen I; Zcharia E; Orgel A; Guatta-Rangini Z; Peretz T; Vlodavsky I; Kleinman HK
Cancer Res; 2003 Dec; 63(24):8821-6. PubMed ID: 14695198
[TBL] [Abstract][Full Text] [Related]
11. Heparan sulfate containing unsubstituted glucosamine residues: biosynthesis and heparanase-inhibitory activity.
Nadanaka S; Purunomo E; Takeda N; Tamura J; Kitagawa H
J Biol Chem; 2014 May; 289(22):15231-43. PubMed ID: 24753252
[TBL] [Abstract][Full Text] [Related]
12. Heparanase promotes growth, angiogenesis and survival of primary breast tumors.
Cohen I; Pappo O; Elkin M; San T; Bar-Shavit R; Hazan R; Peretz T; Vlodavsky I; Abramovitch R
Int J Cancer; 2006 Apr; 118(7):1609-17. PubMed ID: 16217746
[TBL] [Abstract][Full Text] [Related]
13. Molecular properties and involvement of heparanase in cancer progression and mammary gland morphogenesis.
Zcharia E; Metzger S; Chajek-Shaul T; Friedmann Y; Pappo O; Aviv A; Elkin M; Pecker I; Peretz T; Vlodavsky I
J Mammary Gland Biol Neoplasia; 2001 Jul; 6(3):311-22. PubMed ID: 11547900
[TBL] [Abstract][Full Text] [Related]
14. Tamoxifen induces heparanase expression in estrogen receptor-positive breast cancer.
Cohen I; Maly B; Simon I; Meirovitz A; Pikarsky E; Zcharia E; Peretz T; Vlodavsky I; Elkin M
Clin Cancer Res; 2007 Jul; 13(14):4069-77. PubMed ID: 17634531
[TBL] [Abstract][Full Text] [Related]
15. Heparanase: Historical Aspects and Future Perspectives.
Khanna M; Parish CR
Adv Exp Med Biol; 2020; 1221():71-96. PubMed ID: 32274707
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-1258 suppresses breast cancer brain metastasis by targeting heparanase.
Zhang L; Sullivan PS; Goodman JC; Gunaratne PH; Marchetti D
Cancer Res; 2011 Feb; 71(3):645-54. PubMed ID: 21266359
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of OGT2115 inhibition of invasion and migration in KB oral cancer cells. Retracted.
Shen S; Tang JX
Eur Rev Med Pharmacol Sci; 2017 Jan; 21(1):55-60. PubMed ID: 28121356
[TBL] [Abstract][Full Text] [Related]
18. Arctigenin, a lignan from Arctium lappa L., inhibits metastasis of human breast cancer cells through the downregulation of MMP-2/-9 and heparanase in MDA-MB-231 cells.
Lou C; Zhu Z; Zhao Y; Zhu R; Zhao H
Oncol Rep; 2017 Jan; 37(1):179-184. PubMed ID: 27878294
[TBL] [Abstract][Full Text] [Related]
19. Latent heparanase facilitates VLA-4-mediated melanoma cell binding and emerges as a relevant target of heparin in the interference with metastatic progression.
Gerber U; Hoß SG; Shteingauz A; Jüngel E; Jakubzig B; Ilan N; Blaheta R; Schlesinger M; Vlodavsky I; Bendas G
Semin Thromb Hemost; 2015 Mar; 41(2):244-54. PubMed ID: 25682080
[TBL] [Abstract][Full Text] [Related]
20. Thrombin enhances degradation of heparan sulfate in the extracellular matrix by tumor cell heparanase.
Benezra M; Vlodavsky I; Bar-Shavit R
Exp Cell Res; 1992 Jul; 201(1):208-15. PubMed ID: 1612123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
